Neurology

COVID-19 Prompts 'Lifesaving' Policy Change for Opioid Addiction



In the face of COVID-19, SAMHSA has announced policy changes that will allow some patients in treatment for opioid use disorder to receive a 28-day take-home supply of medication.
Medscape Medical News

Source link

Related posts

neurological; +521 new citations

Newsemia

Assessing average somatic CAG repeat instability at the protein level

Newsemia

Analysis of the TMEM230 gene in patients with multiple system atrophy

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World